Virulence factors and resistance mechanisms of Serratia marcescens: A short review

Acta Microbiologica et Immunologica Hungarica

Volumn 53, Issue 1, 2006, Pages 89-93

  Rodrigues, Ana P ^a   Holanda, A R M ^a   Lustosa, G P ^a   Nobrega S M B ^a   Santana, Willma J ^a   Souza, Luciana B S ^a   Coutinho, H Douglas M ^a,b  

^a Fmj   (Brazil)

^b REGIONAL UNIVERSITY OF CARIRI   (Brazil)

Author keywords

Gram negative; Infections; Opportunistic pathogen; Resistance; Serratia marcescens

Indexed keywords

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; NEGIBACTERIA; SERRATIA; SERRATIA MARCESCENS;

ANTIINFECTIVE AGENT; PROTON PUMP; VIRULENCE FACTOR;

DRUG EFFECT; ENTEROBACTER INFECTION; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; REVIEW; SERRATIA MARCESCENS;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PROTON PUMPS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; VIRULENCE FACTORS;

EID: 33744983962     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.53.2006.1.6     Document Type: Review

References (18)

1. Dossi, M. T., Escalona, M., Serrano, C., Silva, M. A., Juliet, C., Valdéz, A. F., Leiva, V., Fernandez, J.: Serratia marcescens: Descripción de un brote de infección intrahospitalaria. Rev Chil Infect 19(4), 262-266 (2002).
2. Marty, K. B., Williams, C. L., Guynn, L. J., Benedik, M. J., Blanke, S. R.: Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens. Infection and Immunity 70(3), 1121-1128 (2002).
3. Johnson, J. S., Croall, J., Power J. S. F., Armstrong, G. R.: Fatal Serratia marcescens meningitis and myocarditis in a patient with an indwelling urinary catheter. J Clin Pathol 51, 789-790 (1998).
4. Ledermann, W.: Shakespeare y la prodigiosa historia, de Serratia marcescens como marcador biológico. Rev Chil Infect. Edición aniversario; 74-75 (2003).
5. Hertle, R., Schwarz, H.: Serratia marcescens internalization and replication in human bladder epithelial cells. BMC Infectious Diseases 4, 16 (2004).
6. Kurz, C. L., Chauvet, S., Andrès, E., Aurouze, M., Vallet, I., Michel, G. P. F., Uh, M., Celli, J., Filloux, A., Bentzmann, S., Steinmetz, I., Hoffmann, J. A., Finlay, B. B., Gorvel, J. P., Ferrandon, D., Ewbank, J. J.: Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. The EMBO Journal 22(7), 1451-1460 (2003).
7. Franzon, J. H., Santos, D. S.: A role for histone-like protein H1 (H-NS) in the regulation of hemolysin expression by Serratia marcescens. Regulation of Serratia marcescens hemolysin genes. Braz J Med Biol Res 37(12), 1763-1769 (2004).
8. Carbonel, G. V., Alfieri, A. F., Alfieri, A. A., Vidotto, M. C., Levy, C. E., Darini, A. C. E., Yanaguita, R. M.: Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. Braz J Med Biol Res 30(11), 1291-1298 (1997).
9. Carbonell, V., Amorim, C. R. N., Furumura, M. T., Darin, A. L. C., Fonseca, B. A. L., Yano, T.: Biological activity of Serratia marcescens cytotoxin. Braz J Med Biol Res 36(3), 351-359 (2003).
10. Chen, J., Lee, E. W., Kuroda, T., Mizushima, T., Tsuchiya, T.: Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance. Biol Pharm Bull 26(3), 391-393 (2003).
11. Kumar, A., Worobec, E. A.: Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump. J Antimicrob Chem 5, 593-596 (2002).
12. Berlanga, M., Viñas, M.: Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens. J Antimicrob Chem 46, 279-282 (2000).
13. Brito, A., Pérez, J., Andrade, E., Cerrada, O., Tovar, L., Guzmán, M., Carmona, O.: Resistencia de Serratia marcescens a los antimicrobianos en Venezuela. BSVM 20(1), 31-36 (2000).
14. Dói, Y., Yokoyama, K., Yamane, K., Wachino, J., Shibata, N., Yagi, T., Shibayama, T., Kato, H., Arakawa, Y.: Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother 48(2), 491-496 (2004).
15. Mahlen, S. D., Morrow, S. S., Abdalhamid, B., Hanson, N. D.: Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J Antimcrob Chem 51, 791-802 (2003).
16. Goto, M., Yasuzawa, H., Higashi, T., Yamaguchi, Y., Kawanami, A., Mifune, S., Mori, H., Nakayama, H., Harada, K., Arakawa, Y.: Dependence of hydrolysis of β-lactams with a Zinc(II)-β-lactamase produced from Serratia marcescens (IMP-1) on pH and concentration of Zinc(II) ion: Dissociation of Zn(II) from IMP-1 in acidic medium. Biol Pharm Bull 26(5), 589-594 (2003).
17. Barbosa, P. A., Morgado, A. M. C., Leonel, R. G., Rojas, G. L., González, R. G.: Marcadores fenotípicos de Serratia marcescens, aislada de un brote intrahospitalario. Rev Mex Patol Clín 46(4), 238-242 (1999).
18. Kirikae, T., Tokunaga, O., Inoue, Y., Fukino, T., Saruta, K., Yoshikura, H., Kuratsuji, T., Miyanomae, T.: Molecular Epidemiology of methicilin-resistant Staphylococcus aureus, Pseudomonas aureginosa and Serratia marcescens in a long-term care facility for patients with severe motor and intellectual disabilities. Jpn J Infect Dis 57, 78-80 (2004).